Global Rainbow Foundation : stem cell treatment and Neuro-rehabilitation therapy to cure Neurological disorders

The Global Rainbow Foundation, a charitable trust in Mauritius, welcomed a team of doctors from India, from the NeuroGen brain & Spine Institute on Saturday 2nd December. The program, which was in collaboration with Anna Medical College, was a CPD-accredited two-hour conference on the theme of Stem Cell treatment and Neuro-rehabilitation therapy.

The event was co-sponsored by Ajanta Pharma Ltd. The medical team comprised of Dr. Alok Sharma, Director & Consultant Neurosurgeon of NeuroGen, Dr. Nandini Gokulchandran, the Deputy Director & Head of Medical Services & Consultant Regenerative Medicine, Dr Amruta Paranjape, physiotherapist and Ms. Sharon Kinkar, the NeuroGen’s marketing coordinator.

The participants of the conference comprised of various doctors, physiotherapists, occupational therapists, psychologists and other health professionals. The conference was followed by a Q & A session. Various books on autism, spinal cord injury, stem cell treatment & stroke were distributed to the attendees, along with a CD on Stem Cell Treatment.

Dr Alok Sharma: “Stem Cell Treatment is a ray of hope for many”

Dr Alok Sharma explained how Stem Cell Treatment can help patients with neurological disorders such as autism, muscular dystrophy, cerebral palsy, mental retardation, spinal cord injury and stroke. “Stem cell treatment has proven to be a ray of hope for conditions which were commonly thought as incurable. Although full recovery is not attained, through a multidisciplinary approach, the symptoms of these conditions can be relieved and improve the quality of life patients,” he explained.

For example, patients with cerebral palsy, who previously could not walk at all, underwent stem cell therapy, and after weeks of rehabilitation, they were able to walk with the help assistive devices.  During treatment, doctors use adult stem cells derived from the patient’s own bone marrow, as they are the safest and most feasible type of cells. There are no major ethical and moral issues involved in the use of these cells.

He underlined that since every patient is different; their treatment protocol is customized according to the patient’s requirement. For more information on the NeuroGen Brain and Spine Institute, contact the Global Rainbow Foundation.

By Ahmad Fakuddeen Jilani